A Prospective, Clinical Investigation of the Vanguard 360 Revision Knee

NCT ID: NCT01542580

Last Updated: 2025-11-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

255 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-03-31

Study Completion Date

2031-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate performance of the Vanguard 360 revision knee system utilizing offset on either the tibial component, femoral component, or both in terms of the restoration of mechanical alignment, clinical outcomes and survivorship.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This investigation is being conducted on a new complete revision knee system, Vanguard 360, which incorporates:

* Fixed Bearing Knee - Vanguard SSK360 with PS Bearing and PSC Bearing
* Fixed Bearing Knee - Vanguard SSK360 TiNbN Femur with PS Bearing and PSC Bearing
* Mobile Bearing Knee - Vanguard DA360 (only being collected in Europe)

The purpose of this study is to evaluate performance of the Vanguard 360 revision knee system utilizing offset on either the tibial component, femoral component, or both in terms of the restoration of mechanical alignment, clinical outcomes and survivorship.

The efficacy and performance of the devices will be assessed by improvement of pain, function, range of motion and patient satisfaction measured pre-operatively and post-operatively. Secondary performance and safety will be determined by radiographic investigation, incidence of complications and revision rates.

Surgical techniques and patient care are to be standard for the surgeon participating in the protocol. There will be no experimental or investigational devices used. There will be no experimental or investigational surgical techniques used. The devices and products will be used in accordance with their instructions for use and/or approved labeling.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis Rheumatoid Arthritis Traumatic Arthritis Post Traumatic Deformity Complications; Arthroplasty Deformity of Limb

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Vanguard SSK 360 with PS Bearing

Patients enrolled using a Vanguard SSK 360 Posterior-Stabilized (non-constrained) tibial bearing.

Vanguard SSK 360 with PS Bearing

Intervention Type DEVICE

non-constrained tibial bearing

Vanguard SSK 360 with PSC Bearing

Patients enrolled using a Vanguard SSK 360 Posterior-Stabilized Constrained tibial bearing.

Vanguard SSK 360 with PSC bearing

Intervention Type DEVICE

constrained tibial bearing

Vanguard DA 360

Patients enrolled using a Vanguard DA 360 component.

Vanguard DA 360

Intervention Type DEVICE

Dual-articulation device, only cleared in EU

Vanguard 360 TiNbN Femur with PS Bearing

The Vanguard 360 TiNbN is the same system and functions in the same manner as the non-coated device.

Vanguard 360 TiNbN Femur with PS bearing

Intervention Type DEVICE

non-constrained tibial bearing, titanium niobium nitride coated Vanguard 360 femur

Vanguard 360 TiNbN Femur with PSC Bearing

The Vanguard 360 TiNbN is the same system and functions in the same manner as the non-coated device.

Vanguard 360 TiNbN Femur with PSC bearing

Intervention Type DEVICE

constrained tibial bearing, titanium niobium nitride coated Vanguard 360 femur

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vanguard SSK 360 with PS Bearing

non-constrained tibial bearing

Intervention Type DEVICE

Vanguard SSK 360 with PSC bearing

constrained tibial bearing

Intervention Type DEVICE

Vanguard DA 360

Dual-articulation device, only cleared in EU

Intervention Type DEVICE

Vanguard 360 TiNbN Femur with PS bearing

non-constrained tibial bearing, titanium niobium nitride coated Vanguard 360 femur

Intervention Type DEVICE

Vanguard 360 TiNbN Femur with PSC bearing

constrained tibial bearing, titanium niobium nitride coated Vanguard 360 femur

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Painful and disabled knee joint resulting from osteoarthritis, rheumatoid arthritis, traumatic arthritis where one or more compartments are involved.
* Correction of varus, valgus or post-traumatic deformity
* Correction or revision of unsuccessful osteotomy, arthrodesis, or failure of previous joint replacement procedure
* Ability and willingness of the patient to attend follow-up visit.
* Willing to give written informed consent
* Patients are at least 18 years of age, no upper age limit, must have reached full skeletal maturity.

Exclusion Criteria

* infection
* sepsis
* osteomyelitis

Relative Contraindications:

* An uncooperative patient or a patient with neurologic disorders who is incapable of following directions
* Osteoporosis
* Metabolic disorders which may impair brain function
* Osteomalacia
* Distant foci of infections which may spread to the implant site
* Rapid joint destruction, marked bone loss, or bone resorption apparent on roentgenogram
* Vascular insufficiency, muscular atrophy, neuromuscular disease
* Incomplete or deficient soft tissue surrounding the knee
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Zimmer Biomet

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Emilie Rohmer

Role: STUDY_DIRECTOR

Zimmer Biomet

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Illinois Bone and Joint

Morton Grove, Illinois, United States

Site Status

Orthopedic Institute of Henderson

Henderson, Nevada, United States

Site Status

University of Utah Orthopedic Center

Salt Lake City, Utah, United States

Site Status

OrthoVirginia West End Orthopedic Clinic

Richmond, Virginia, United States

Site Status

University Hopital Pellenberg

Pellenberg, , Belgium

Site Status

Aarhus university hospital

Aarhus, , Denmark

Site Status

Ch Lyon Sud

Lyon, , France

Site Status

Klinik fur Endoprothetik und gelenkchirurgie

Bad Wildbad, , Germany

Site Status

IRCCS Istituto Ortopedico Galeazzi

Milan, , Italy

Site Status

Azienda Ospedaliero Universitaria Pisana

Pisa, , Italy

Site Status

University Hospital Mutua de Terrasa

Terrassa, , Spain

Site Status

Royal Orthopaedic Hospital

Birmingham, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Belgium Denmark France Germany Italy Spain United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

GBMET.CR.G1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Vanguard Rocc Post Market Surveillance
NCT03664791 ACTIVE_NOT_RECRUITING